Currently out of the existing stock ratings of Trevor Allred, 15 are a BUY (100%).

Trevor Allred

Work Performance Price Targets & Ratings Chart

Analyst Trevor Allred, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 66.67% that have a potential upside of 27.3% achieved within 97 days.

Trevor Allred’s has documented 30 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INVA, Innoviva at 23-Sep-2026.

Wall Street Analyst Trevor Allred

Analyst best performing recommendations are on DNTH (DIANTHUS THERAPEUTICS).
The best stock recommendation documented was for DNTH (DIANTHUS THERAPEUTICS) at 11/6/2025. The price target of $62 was fulfilled within 118 days with a profit of $25.57 (70.19%) receiving and performance score of 5.95.

Average potential price target upside

BBIO BridgeBio Pharma DNTH Dianthus Therapeutics INVA Innoviva LGND Ligand Pharmaceuticals LEGN Legend Biotech Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Jun-2026

$108

$33.71 (45.38%)

$106

10 days ago
(02-Nov-2026)

0/3 (0%)

$33 (44.00%)

Buy Since 22-Jul-2019

$100

$25.71 (34.61%)

$110

13 days ago
(30-Oct-2026)

5/9 (55.56%)

$25.05 (33.42%)

215

Buy Since 06-Jan-2026

$88

$13.71 (18.45%)

$87

13 days ago
(30-Oct-2026)

0/6 (0%)

$13.05 (17.41%)

Hold Since 19-May-2026

$91

$16.71 (22.49%)

$93

24 days ago
(19-Oct-2026)

1/3 (33.33%)

$23.06 (33.94%)

51

Buy Since 04-Sep-2024

$120

$45.71 (61.53%)

$115

24 days ago
(19-Oct-2026)

11/15 (73.33%)

$52.06 (76.63%)

188

Show more analysts

Please expand the browser size to see the chart

Which stock is Trevor Allred most bullish on?

Potential upside of $14.76 has been obtained for INVA (INNOVIVA)

What Year was the first public recommendation made by Trevor Allred?

On 2024
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?